Search images on Google      Product Monograph

Active Ingredients:

• sodium polystyrene sulfonate, 1 G/G

DIN: 02497557

Dosage Form(s): POWDER FOR SUSPENSION

Route(s) of Administration: ORAL, RECTAL

Schedule: Prescription

Company: JAMP PHARMA CORPORATION

ATC:

• V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
• V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
• V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, WHO)
• V03AE01 - POLYSTYRENE SULPHONATE (WHO)

Reference brand drug: Kayexalate

Pharmaceutical standard: MFR

 

External Links for Jamp Sodium Polystyrene Sulfonate:

Search on Google

• Jamp Sodium Polystyrene Sulfonate side effects
• Jamp Sodium Polystyrene Sulfonate dosage
• sodium polystyrene sulfonate side effects
• sodium polystyrene sulfonate dosage